Red-flag symptoms such as severe abdominal pain, persistent vomiting, or jaundice require immediate cessation and urgent medical attention
But for someone with a smaller percentage of their body weight to lose, or with health conditions, compounded medications might introduce unnecessary risk, she said
Presentaciones de aGLP-1 de administracin diaria Se debe instruir al paciente sobre las nuevas posologas y condiciones de administracin de estos aGLP-1 (ver tablas anteriores) La semaglutida oral tiene unas condiciones de administracin exigentes que debe conocer el paciente
NICE recommends GLP-1 agonists for adults with BMI 35 kg/m (or 32.5 kg/m for certain ethnic groups) who have at least one weight-related comorbidity and access to a specialist weight management service, typically for up to 2 years
Factors That Could Slow Things Down Safety signals in larger trials
Signs of dehydration (dark urine, dizziness, reduced urine output) should prompt cessation of use and medical review